Global Cell Culture Protein Surface Coating Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

CHAPTER 4 CELL CULTURE PROTEIN SURFACE COATING MARKET, BY COATING TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PRECOATING

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. MULTIWALL/MICROWELL PLATES

4.3.1. Market size and forecast

4.4. FLASKS

4.4.1. Market size and forecast

4.5. PETRI DISHES

4.5.1. Market size and forecast

4.6. SLIDES

4.6.1. Market size and forecast

4.7. COVER SLIPS

4.7.1. Market size and forecast

4.8. SELF-COATING

4.8.1. Key market trends
4.8.2. Growth factors and opportunities
4.8.3. Market size and forecast

CHAPTER 5 CELL CULTURE PROTEIN SURFACE COATING MARKET, BY PROTEIN SOURCE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ANIMAL-DERIVED PROTEIN

5.2.1. Market size and forecast

5.3. HUMAN-DERIVED PROTEIN

5.3.1. Market size and forecast

5.4. SYNTHETIC PROTEIN

5.4.1. Market size and forecast

5.5. PLANT-DERIVED PROTEIN

5.5.1. Market size and forecast

CHAPTER 6 CELL CULTURE PROTEIN SURFACE COATING MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America cell culture protein surface coating market by coating type
6.2.5. North America cell culture protein surface coating market by protein source

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe cell culture protein surface coating market by coating type
6.3.5. Europe cell culture protein surface coating market by protein source

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Taiwan market size and forecast
6.4.3.7. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific cell culture protein surface coating market by coating type
6.4.5. Asia-Pacific cell culture protein surface coating market by protein source

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast

6.5.4. LAMEA cell culture protein surface coating market by coating type
6.5.5. LAMEA cell culture protein surface coating market by protein source

CHAPTER 7 COMPANY PROFILES

7.1. RECKITT BENCKISER GROUP PLC

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. JOHNSON & JOHNSON

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. GLAXOSMITHKLINE PLC

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. NOVARTIS AG

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. BAYER AG

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. ASTRAZENECA PLC

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. SUN PHARMACEUTICAL INDUSTRIES LTD.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. PFIZER INC.

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. PRESTIGE BRANDS HOLDINGS, INC.

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. PROCTER & GAMBLE CO.

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments